WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Aug. 17, 2006--Merck said it will appeal the decision returned by a New Orleans jury today in the second federal VIOXX case to go trial, Barnett v. Merck. “We disagree with the jury’s verdict. The plaintiff was at increased risk for a heart attack regardless of whether he was taking VIOXX,” said Phil Beck of Bartlit Beck, Merck’s lead trial lawyer in the case.
